Product manufactures embrace Flax Lignan SDG content, labeling recommendations and health-specific products
Minneapolis – Acatris today presented information regarding the growth of dietary supplements containing standardized flax lignan ingredients and the increased health benefits being associated with flax lignan consumption. The presentation was part of the Functional Foods & Nutraceuticals (FF&N) web-based seminar “Focus on Flax Lignans and the EFA Category.”
Acatris, the flax lignan leader, set the gold standard for minimum amount needed for therapeutic benefit and research on the health benefits of flax lignans. Lignans are a group of phytochemicals found in many plants. Each type of lignan has a different structure and different health properties. The main flaxseed lignan is SDG.
Based on research, consumers need a minimum of 50 mg a day of SDG to reap the health benefits attributed to the ingredient. Research shows flax lignans may help improve prostate health, breast health, reduce menopausal symptoms, provide support for men suffering from hair loss, and acne.
According to presenter Kelley C. Fitzpatrick, Flax Canada, growth in the specialty supplement category including flax lignan products is up 8.1 percent overall in 2004 over 2003. As Fitzpatrick explained, this is one of the few areas demonstrating substantial growth during this period. Specialty supplements increased to more than $2.9 billion in annual sales in 2004, and 2005 is expected to demonstrate continued growth in this category.
“SDG, the main flax lignan has been part of the human diet for centuries. It’s bioavailability and health benefits are well documented,” said Jocelyn Mathern, R.D. and Technical Specialist for Acatris Inc. “The number of products including standardized flax lignans and targeting specific health benefits have seen tremendous growth in the last four to five years including products focusing on women’s health, prostate health and breast health. These products help bring this essential nutrient, flax lignans, to consumers looking for targeted health benefits.”
According to seminar moderator, Todd Runestad, Science Editor for FF&N, flax lignan SDG is the most studied lignan and the most science-supported lignan ingredient. “Other lignan sources are available; however, the science is far more limited than that for flax SDG lignans," said Runestad.
In 2005, Acatris initiated a proactive consumer education campaign and launched the Flax Lignan Information Bureau website (www.flaxlignaninfo.com), gaining marketplace leadership status that has driven sales and key business deals.
Acatris announced in November 2005, a 300-percent sales increase between March 1, 2005 and October 1, 2005 for their LinumLife® EXTRA product over the entire 2004 sales figures for the previous year. LinumLife® EXTRA is the first flax extract with a standardized 20% lignan concentration. Acatris also secured a major licensing agreement with Archer Daniels Midland Company (ADM) regarding the sales of soy isoflavone extracts.
Acatris’ education campaign also played an essential part in a recent announcement between Acatris and ADM to form the first standardized flax lignan industry association, the Flax Lignan Association.
Acatris will be presenting additional information at their seminar at Natural Products Expo West in Anaheim, CA, on Saturday, March 25, 2006 at 1 pm in Room 207C. For more information, please contact Acatris. Also, FF&N will be archiving the presentation on their website.
Acatris Inc.’s LinumLife® EXTRA is produced through a patented production process. A dosage of 250 mg of LinumLife® EXTRA provides 50 mg lignans. This ingredient offers the convenience for one-per-day lignan capsules or tablets. For more information on LinumLife® EXTRA or flax lignans, visit www.linumlife.com or visit the Flax Lignan Information Bureau at www.flaxlignaninfo.com.